Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial.

Knip M, Åkerblom HK, Becker D, Dosch HM, Dupre J, Fraser W, Howard N, Ilonen J, Krischer JP, Kordonouri O, Lawson ML, Palmer JP, Savilahti E, Vaarala O, Virtanen SM; TRIGR Study Group.

JAMA. 2014 Jun 11;311(22):2279-87. doi: 10.1001/jama.2014.5610.

2.

Dunnigan-type familial partial lipodystrophy associated with the heterozygous R482W mutation in LMNA gene - case study of three women from one family.

Nabrdalik K, Strózik A, Minkina-Pędras M, Jarosz-Chobot P, Młynarski W, Grzeszczak W, Gumprecht J.

Endokrynol Pol. 2013;64(4):306-11.

3.

Routine sensor-augmented pump therapy in type 1 diabetes: the INTERPRET study.

Nørgaard K, Scaramuzza A, Bratina N, Lalić NM, Jarosz-Chobot P, Kocsis G, Jasinskiene E, De Block C, Carrette O, Castañeda J, Cohen O; Interpret Study Group.

Diabetes Technol Ther. 2013 Apr;15(4):273-80. doi: 10.1089/dia.2012.0288. Epub 2013 Feb 25.

4.

Growth differences between North American and European children at risk for type 1 diabetes.

Nucci AM, Becker DJ, Virtanen SM, Cuthbertson D, Softness B, Huot C, Wasikowa R, Dosch HM, Akerblom HK, Knip M; TRIGR Study Group.

Pediatr Diabetes. 2012 Aug;13(5):425-31. doi: 10.1111/j.1399-5448.2011.00840.x. Epub 2012 Jan 17.

5.

Nonketotic hyperosmolar syndrome as an acute complication of type 1 diabetes onset in a 20-month-old boy with congenital central nervous system defect.

Chumiecki M, Minkina-Pedras M, Chobot A, Jarosz-Chobot P.

Pediatr Endocrinol Diabetes Metab. 2012;18(1):40-4.

PMID:
22525691
6.

Prospective assessment of continuous subcutaneous insulin infusion therapy in young children with type 1 diabetes.

Minkina-Pedras M, Jarosz-Chobot P, Polanska J, Kalina MA, Marcinkowski A, Malecka-Tendera E.

Diabetes Res Clin Pract. 2009 Aug;85(2):153-8. doi: 10.1016/j.diabres.2009.05.016. Epub 2009 Jun 18.

PMID:
19539392
7.

[Coexistance of autoimmunological diseases with type 1 diabetes mellitus in young patients based on literature and own experience].

Otto-Buczkowska E, Jarosz-Chobot P, Minkina-Pedras M, Deja G, Kalina-Faska B.

Przegl Lek. 2008;65(3):140-4. Review. Polish.

PMID:
18624123
8.

[Treatment of type 1 diabetes mellitus revealed below 7 years of age in the Diabetes Center of Silesia, Poland].

Chobot AP, Deja G, Marcinkowski A, Myrda A, Minkina-Pedras M, Jarosz-Chobot P, Otto-Buczkowska E.

Pediatr Endocrinol Diabetes Metab. 2007;13(2):75-8.

PMID:
17880811
9.

[Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus].

Minkina-Pedras M, Jarosz-Chobot P, Małecka-Tendera E, Deja G.

Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2005;11(3):171-6. Polish.

PMID:
16232370
10.

[Lipid disturbances in type 1 diabetes mellitus--cardiovascular risk factor].

Pedras J, Jarosz-Chobot P, Minkina-Pedras M, Deja G.

Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2005;11(2):97-101. Review. Polish.

PMID:
15996339
11.

[Diabetic cataract during the first year of diabetes - report of the case].

Muchacka-Bianga M, Deja G, Jarosz-Chobot P, Minkina-Pedras M, Koehler B.

Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2002;8(1):45-6. Polish.

PMID:
12818131

Supplemental Content

Loading ...
Support Center